// App-Quantinova.ai

T4091 2016 AHA : Safety of Disopyramide in Patients With Hypertrophic Cardiomyopathy - Is Initation of Therapy in Hospital Really Required?

Researchers

Presenter

  • Fourey Dana

Principal Investigators

  • Adaya Weissler-Snir

  • Waseem Hindieh

  • Raymond Chan

  • Michael Gollob

  • Harry Rakowski

Medical Centers

  • Toronto Western Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Left ventricular outflow tract obstruction

  • Hypertrophic cardiomyopathy

  • Cardiac arrest

  • Heart muscle disease

  • Arrhythmia

  • Syncope

Biomarkers

  • N/A

Drug/Treatment

  • disopyramide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved